Drug Profile
Interferon beta-1a biosimilar - Dong-A ST
Alternative Names: DA-3051; IFN-β biosimilar - Dong-A ST; Interferon beta-1a (IFN β-1a) - Dong-A STLatest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator Dong-A Pharmaceutical
- Developer Dong-A ST
- Class Antiasthmatics; Antineoplastics; Antivirals; Interferons; Recombinant proteins; Vascular disorder therapies
- Mechanism of Action Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Multiple sclerosis
Highest Development Phases
- No development reported Multiple sclerosis
Most Recent Events
- 01 Sep 2010 DA 3051 is available for licensing. www.donga-pharm.com